Status:
COMPLETED
Behavioral Activation/Armodafinil to Treat Fatigue in HIV/AIDS
Lead Sponsor:
Research Foundation for Mental Hygiene, Inc.
Conditions:
Hiv
Fatigue
Eligibility:
All Genders
18-70 years
Phase:
PHASE4
Brief Summary
This is an integrated medication/behavioral intervention program to increase energy, activity level and goal attainment in a sample of HIV+ adults whose presenting problems include both clinically sig...
Detailed Description
The investigators propose an integrated medication/behavioral intervention program to increase energy, activity level and goal attainment in a sample of people with HIV/AIDS whose presenting problem i...
Eligibility Criteria
Inclusion
- HIV+, ages 18-70
- Under the care of a medical provider
- Clinically significant fatigue
- Speaks English
- Able and willing to give informed consent
- Patient seeks either work or vocational training but is blocked from doing so by current fatigue
Exclusion
- Primary care provider does not approve of study participation
- Medical rule-outs such as anemia, hypothyroidism, hypogonadism or other condition that may account for fatigue
- Abnormal EKG
- Untreated major depressive disorder; psychosis, bipolar disorder
- Current substance abuse/dependence
- Clinically significant suicidal ideation
Key Trial Info
Start Date :
July 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2014
Estimated Enrollment :
46 Patients enrolled
Trial Details
Trial ID
NCT01158443
Start Date
July 1 2010
End Date
March 1 2014
Last Update
December 21 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
New York State Psychiatric Institute
New York, New York, United States, 10032